RECENT ADVANCES IN THE TREATMENT OF PARKINSONS-DISEASE - THE ROLE OF BROMOCRIPTINE

被引：31

作者：

LEWITT, PA ^{[1
]}

CALNE, DB ^{[1
]}

机构：

[1] NINCDS,PROGRAM INTRAMURAL RES,EXPTL THERAPEUT BRANCH,BLDG 10,ROOM 6D20,BETHESDA,MD 20205

来源：

关键词：

D O I：

10.1007/BF01664014

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：175 / 184

页数：10

共 23 条

[1] CALNE DB, 1978, LANCET, V1, P735
[2] EFFECT OF ERGOT DRUGS ON CENTRAL CATECHOLAMINE NEURONS - EVIDENCE FOR A STIMULATION OF CENTRAL DOPAMINE NEURONS
CORRODI, H
FUXE, K
HOKFELT, T
LIDBRINK, P
UNGERSTEDT, U
[J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1973, 25 (05) : 409 - 412
[3] DUVOISIN R, 1978, S DOPAMINERGIC ERGOT, P329
[4] EISLER T, NEUROLOGY
[5] FAHN S, 1979, 1978 S DOP ERG DER M, P303
[6] GODWINAUSTEN RG, 1979, 1978 S DOP ERG DER M, P297
[7] INCONTINENCE OF URINE WITH LONG-TERM BROMOCRIPTINE THERAPY
GOPINATHAN, G
CALNE, DB
[J]. ANNALS OF NEUROLOGY, 1980, 8 (02) : 204 - 204
[8] GOPINATHAN G, NEUROLOGY
[9] FIBROTIC DISORDERS ASSOCIATED WITH METHYSERGIDE THERAPY FOR HEADACHE
GRAHAM, JR
SUBY, HI
LECOMPTE, PR
SADOWSKY, NL
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1966, 274 (07) : 359 - &
[10] GRON U, 1979, 1978 S DOP ERG DER M, P343